Clinical Trial Update: Therapeutic Effect of Sildenafil in Patients With Coronary Vasospasm [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating sildenafil for coronary vasospasm was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Vasospasm

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Udo Sechtem | Conditions: Coronary Vasospasm | Phase 3 | Status: WITHDRAWN